Institute of Pathology First Faculty of Medicine Charles University. Ovary

Similar documents
3 cell types in the normal ovary

3 cell types in the normal ovary

Pathology of the female genital tract

Pathology of Ovarian Tumours. Dr. Jyothi Ranganathan MD ( Path) AFMC Pune PDCC (Cytopathology) PGI Chandigarh

OVARIES. MLS Basic histological diagnosis MLS HIST 422 Semester 8- batch 7 L13 Dr: Ali Eltayb.

Springer Healthcare. Understanding and Diagnosing Ovarian Cancer. Concise Reference: Krishnansu S Tewari, Bradley J Monk

Gynaecological Malignancies

Journal of Rawalpindi Medical College (JRMC); 2016;20(4):

The Adnexal Mass. Handout NCUS 3/18/2017 Suzanne Dixon, MD

See the latest estimates for new cases of ovarian cancer and deaths in the US and what research is currently being done.

GYNECOLOGIC MALIGNANCIES: Ovarian Cancer

Female Reproduc.ve System. Kris.ne Kra7s, M.D.

Case 1. Pathology of gynecological cancer. What do we need to know (Case 1) Luca Mazzucchelli Istituto cantonale di patologia Locarno

of 20 to 80 and subsequently declines [2].

The relative frequency and histopathological patterns of ovarian lesions: study of 116 cases

Histological pattern of ovarian tumors and their age distribution

L/O/G/O. Ovarian Tumor. Xiaoyu Niu Obstetrics and Gynecology Department Sichuan University West China Second Hospital

Histopathological analysis of neoplastic and non neoplastic lesions of ovary: A study of one hundred cases

ISUOG Basic Training Typical Ultrasound Appearances of Common Pathologies in the Adnexae

Icd 10 ovarian stroma

Mousa. Najat kayed &Renad Al-Awamleh. Nizar Alkhlaifat

Female Reproduc.ve System. Kris.ne Kra7s, M.D.

Diane DeFriend Derriford Hospital, Plymouth

Diagnostic accuracy of ultrasonography with color doppler imaging techniques in adnexal masses and correlation with histopathological analysis

Fast Facts: Ovarian Cancer

Histopathological Study of Ovarian Lesions

2/24/19. Ovarian pathology: IOTA ADNEXAL MASSES. Content. IOTA terms for description of an adnexal mass. IOTA terms for description of an adnexal mass

7 Mousa. Obada Zalat. Mohammad Badi

JMSCR Vol 04 Issue 06 Page June 2016

EDUCATIONAL COMMENTARY CA 125. Learning Outcomes

JMSCR Vol 3 Issue 9 Page September 2015

Section 1. Biology of gynaecological cancers: our current understanding

Endosalpingiosis. Case report

Clinicopathological and Histological Features of Ovarian Tumour- A Study

H&E, IHC anti- Cytokeratin

Invited Re vie W. Molecular genetics of ovarian carcinomas. Histology and Histo pathology

Ovarian Tumors: A Study of 2146 Cases at AFIP, Rawalpindi, Pakistan.

Serous borderline tumor icd 10

Annual report of Gynecologic Oncology Committee, Japan Society of Obstetrics and Gynecology, 2013

Ovarian cancer: 2012 Update Srini Prasad MD Univ Texas MD Anderson Cancer Center

CONTINUING EDUCATION IN TOXICOLOGIC PATHOLOGY REPRODUCTIVE SYSTEM

Top Tips for Gynaecological Ultrasound. Catherine Kirkpatrick Consultant Sonographer Dublin Oct 2018

PATHOLOGY OF THE FEMALE GENITAL TRACT

ORIGINAL RESEARCH ARTICLE

Ovarian tumors - Incidence and histopathological spectrum in tertiary care center, Valsad

JMSCR Vol 04 Issue 12 Page December 2016

Cytology and Surgical Pathology of Gynecologic Neoplasms

RARE EPITHELIAL TUMOURS OF BREAST RARE EPITHELIAL TUMOURS OF CORPUS UTERI EPITHELIAL TUMOURS OF CERVIX UTERI

Dr Sanjiv Manek Oxford. Oxford Pathology Course 2010 for FRCPath Illustration-Cellular Pathology. Oxford Radcliffe NHS Trust

2/9/2015. Bartholin Cyst. Vulva: Squamous epithelium skin. Vagina: Squamous epithelium mucosa. Cervix: Ectocervix: squamous Endocervix: glandular

Female Genital Tract Lab. Dr. Nisreen Abu Shahin Assistant Professor of Pathology University of Jordan

Annual report of the Committee on Gynecologic Oncology, the Japan Society of Obstetrics and Gynecology

Histopathological Study of Spectrum of Lesions Seen in Surgically Resected Specimens of Fallopian Tube

HISTOPATHOLOGICAL SPECTRUM OF OVARIAN TUMORS: A DESCRIPTIVE STUDY. Dissertation submitted in

Oppgave: MED5600_OPPGAVE04_V18_ORD

Vulva Inflammatory Disorders Lichen Planus Fixed Drug Eruption Erythema Multiforme Plasmacytosis Mucosae (Zoon) Lichen Sclerosus Allergic Contact

Current Concept in Ovarian Carcinoma: Pathology Perspectives

Retrospective Study of Spectrum of Ovarian Tumours in a Tertiary Care Setup. Vimala Chelladurai*, Vimal Chander and Chitra Srinivasan ABSTRACT

Characterizing Adnexal Masses: Pearls and Pitfalls 20 th Annual Summer Practicum SCBT-MR Jackson Hole August 11, 2010

Original Article Histological patterns of Ovarian neoplasms A five year experience in North-East India Saha M 1, Banerjee A 2, Datta A 3

How to Recognize Gynecologic Cancer Cells from Pelvic Washing and Ascetic Specimens

Original Article INTRODUCTION. Abstract

Low-grade serous neoplasia. Robert A. Soslow, MD

Unexpected Gynecologic Findings at Laparotomy. Susan A. Davidson, MD University of Colorado, Denver School of Medicine

Multiple Synchronous Lesions in the Genital Tract of a Female: A Rare Combination with Unrelated Histogenesis

ICD-O Morphology code. R=Rare Tier Tumour ICD-O Topography code C30.0, C31

Ovarian Germ Cell Tumor Histopathological and statistical analysis

Study of morphological patterns of ovarian neoplasms

Clinicopathological Analysis of Ovarian Tumours at Birendra Military Hospital

Adnexal ovarian cyst icd 10 Adnexal ovarian cyst icd 10

Note: The cause of testicular neoplasms remains unknown

بسم هللا الرحمن الرحيم. Prof soha Talaat

Exploring the Histogenesis of Ovarian Mucinous and Transitional Cell (Brenner) Neoplasms and Their Relationship With Walthard Cell Nests

Histological Pattern of Ovarian Neoplasma

Adenocarcinoma of the Cervix

Cancer arising from Endometriosis and Its Clinical implications

Ovarian Cancer. What is cancer?

Assessment of adnexal masses. Ultrasound workup of adnexal masses. symptoms. symptoms. Age. Serum tumor markers 10/1/2018

Childhood and adolescent ovarian malignant tumors in Israel A nationwide study

Type I. Type II. Excess estrogen Lynch Endometrioid adenocarcinoma PTEN. High grade More aggressive Serous, Clear Cell p53

OVARIAN CYSTS (A HISTOPATHOLOGICAL STUDY)

Mucinous Tumors of the Ovary Beirut, Lebanon. Anaís Malpica, M.D. Professor Department of Pathology

3/25/ % arise from coelomic epithelium

JMSCR Vol 07 Issue 02 Page February 2019

Human epididymal protein 4 The role of HE4 in the management of patients presenting with pelvic mass Publication abstracts

FREQUENCY AND HISTOLOGICAL SPECTRUM OF MALIGNANT OVARIAN TUMOURS AT KING EDWARD MEDICAL UNIVERSITY, LAHORE

Neoplasias Quisticas del Páncreas

-The cause of testicular neoplasms remains unknown

A Serous Borderline Tumor of the Fallopian Tube Detected Incidentally

The Origin of Pelvic Low-Grade Serous Proliferative Lesions

The Diagnostic Challenges of Low Grade and High Grade Tubo-Ovarian Serous Carcinomas. W Glenn McCluggage Belfast, Northern Ireland

Ovarian Cancer What you need to know

A study of benign adnexal masses

Protocol for the Examination of Lymphadenectomy Specimens From Patients With Malignant Germ Cell and Sex Cord-Stromal Tumors of the Testis

Published Ahead of Print on September 28, 2012 as /theoncologist

Histopathological study of ovarian lesions in a tertiary care center in Hyderabad, India: a retrospective five-year study

Case # 4 Low-Grade Serous Carcinoma (Macropapillary) of the Ovary Arising in an Atypical Proliferative Serous Tumor

Ovarian Cancer Causes, Risk Factors, and Prevention

ORIGINAL ARTICLE CA-125 AS A SURROGATE MARKER IN A CLINICAL AND HISTOPATHOLOGICAL STUDY OF PELVIC MASS AT A TERTIARY CARE HOSPITAL

Transcription:

Ovary

Barrett esophagus ph in vagina between 3.8 and 4.5 ph of stomach varies from 1-2 (hydrochloric acid) up to 4-5 BE probably results from upward migration of columnar cells from gastroesophageal junction (GEJ) GEJ cells are also origin of gastric-type metaplasia in distal esophagus It is unclear whether gastric-type metaplasia is a precursor to intestinal type metaplasia or whether they are separate entities

Diseases of the ovary nonneoplastic lesions - pelvic inflammatory disease - ovarian cysts - endometriosis ovarian tumors - epithelial (surface epithelial-stromal) - sex cord-stromal - germ cell - germ cell sex-cord stromal

Nonneoplastic inclusion functional endometrioid Ovarian cysts Cystic tumors epithelial tumors - cystadenoma (benign, borderline) - cystadenocarcinoma germ cell tumors - dermoid cyst

Nonneoplastic cysts inclusion cysts - inclusions of the surface epithelium - inclusions from fimbrial epitehlium functional cysts - follicular cyst - corpus luteum cyst - hemorrhagic cyst endometrioid cyst

Nonneoplastic cysts inclusion cysts - inclusions of the surface epithelium - inclusions from fimbrial epitehlium functional cysts - follicular cyst - corpus luteum cyst - hemorrhagic cyst - simple unilocular cysts - up to 1 cm in diameter - larger cyst - cystadenoma endometrioid cyst

Nonneoplastic cysts - unilocular thin walled cysts inclusion cysts - more than 3 cm in diameter - inclusions of the surface epithelium - content: serous, serosanguineous, - inclusions from fimbrial epitehlium clotted blood functional cysts - follicular cyst - corpus luteum cyst - hemorrhagic cyst endometrioid cyst

Nonneoplastic cysts inclusion cysts - thick and fibrotic wall - up to 15 cm in diameter - cyst content: semifluid, chocolate-colored functional cysts material - inclusions of the surface epithelium - inclusions from fimbrial epitehlium - follicular cyst - corpus luteum cyst - hemorrhagic cyst endometrioid cyst

Ovarian tumors

Classification of ovarian tumors epithelial tumors sex cord-stromal tumors germ cell tumors germ cell sex cord-stromal tumors

Classification of epithelial tumors according to their gross features: - cystadenoma (cystadenocarcinoma) - cystadenofibroma - adenofibroma (adenocarcinofibroma) - surface papilloma (surface papillary carcinoma) according to their histogenesis

Classification of epithelial tumors according to their gross features: - cystadenoma (cystadenocarcinoma) - cystadenofibroma - adenofibroma (adenocarcinofibroma) - surface papilloma (surface papillary carcinoma) according to their histogenesis!!!

Epithelial tumors benign borderline malignant serous - low grade - high grade endometrioid clear cell mucinous

Surface epithelial tumors benign borderline Tumors of müllerian origin malignant Müllerian (paramesonephric) ducts will give rise to: - upper vagina - cervix - uterus - Fallopian tube serous - low grade - high grade endometrioid clear cell mucinous

Benign epithelial tumors can be large (especially mucinous tumors the world s biggest tumor weighted 136 kilos) symptoms and signs usually nonspecific: - pelvic pain - discomfort - an asymptomatic pelvic mass up to 25% of tumors bilateral

Benign serous cystadenoma

Benign mucinous cystadenoma

Borderline tumors increased epithelial proliferation do not display invasion usually behave in a benign fashion but behavior can be malignant clinical features similar to those for benign tumors

Serous borderline tumor

Serous borderline tumor

Borderline tumor vs. carcinoma Borderline tumor Median age 46 56-60 % of tumor in 60-80 20-30 stage I 5-year survival 95-98 % 85-93 % rate for stage I 5-year survival 86-92 % 60-74 % rate for stage II 5-year survival 17-33 % 23-41 % rate for stage III metastatic spread rare common Invasive caricnoma

Ovarian cancer about 30% of all cancers of the female genital tract incidence rates are highest in the economically advanced countries (most frequent cause of death due to gynecological cancer) epithelial carcinomas account for 90% of these cancers in North America and Western Europe in some Asian countries, including Japan, germ cell tumours account for a significant proportion (20%) of ovarian malignancies

Risk factors age reproductive factors - early menarche, late menopause high socioeconomic status - lower fertility BRCA1/2 mutation (5-10% hereditary) Ovarian cancer Protective factors increased parity oral contraceptive use surgically induced: - hysterectomy - tubal ligation - bilateral salpingooophorectomy

Ovarian cancer: age-standardised (world) incidence and mortality rates per 100 000 (all ages) in 18 world regions Sankaranarayanan R, Ferlay J. Worldwide burden of gynaecological cancer: the size of the problem. Best Pract Res Clin Obstet Gynaecol. 2006 Apr;20(2):207-25. http://dx.doi.org/10.1016/j.bpobgyn.2005.10.007

Incidence and mortality Czech Republic 2006 Incidence Mortality 1074 cases 764 deaths 20,4 / 100 000 women 14,5 / 100 000 women 6,1%

high grade serous (70%) y ne og ci ol di th Me Pa of ity of ty rs te ul ive itu ac n st F U In rst les Fi har low grade serous (<5%) C surface epithelialstromal tumors endometrioid (10%) clear cell (10%) mucinous (3%)

y ne og ci ol di th Me Pa of ity of ty rs te ul ive itu ac n st F U In rst les Fi har C surface epithelialstromal tumors high grade serous (70%) Supposed origin of surface epithelial-stromal tumors according lowwho: grade serous (<5%) to mesothelial surface lining of the ovaries endometrioid (10%) and/or invagination of this lining into the ovarian cortex (inclusion cysts) clear cell (10%) mucinous (3%)

1) intraepithelial carcinoma in the tubal fimbriae 2) endosalpingiosis (inclusions from fimbrial epithelium) 3) inclusions from surface epithelium high grade serous (70%) low grade serous(<5%) precursor lesion: serous borderline tumor Epithelial tumors Precursor lesions and origin: unknown Putative precursor lesions: 1) endometriosis 2) mucinous metaplasia of Walthard nests 3) some can be of germ cell origin endometrioid (10%) clear cell (10%) mucinous (3%) precursor lesion: endometriosis precursor lesion: endometriosis

High grade serous carcinoma

High grade serous carcinoma y ne og ci ol di th Me Pa of ity of ty rs te ul ive itu ac n st F U In rst les Fi har C

y ne og ci ol di th Me Pa of ity of ty rs te ul ive itu ac n st F U In rst les Fi har C

Clear cell carcinoma

Clear cell carcinoma y ne og ci ol di th Me Pa of ity of ty rs te ul ive itu ac n st F U In rst les Fi har C

Prognostic factors C y ne og ci ol di th Me Pa of ity of ty rs te ul ive itu ac n st F U In rst les Fi har histologic subtype histologic grade stage advanced cancer: - macroscopic absence of residual tumor after primary surgery

Sex cord-stromal tumors C y ne og ci ol di th Me Pa of ity of ty rs te ul ive itu ac n st F U In rst les Fi har about 8 % of all ovarian tumors composed of: granulosa cells theca cells fibroblasts of stromal origin Sertoli cells Leydig cells singly or in various combinations

Sex cord-stromal tumors (adult or juvenile type) C y ne og ci ol di th Me Pa of ity of ty rs te ul ive itu ac n st F U In rst les Fi har about 8 % of all ovarian tumors composed of: granulosa cells theca cells fibroblasts of stromal origin Sertoli cells Leydig cells granulosa cell tumor singly or in various combinations thecoma fibroma fibrosarcoma Sertoli cell tumor Leydig cell tumor

Germ cell tumors different tumor types derived from the primitive germ cells of the embryonic gonad represents: - about 30% of all ovarian tumors (up to 95 % are mature cystic teratomas) - about 3 % of all ovarian cancers (western world) - up to 20 % of all ovarian cancers (Asia)

Germ cell tumors - histogenesis Dysgerminoma Germ cell Tumors of totipotential cells Embryonal carcinoma Embryonal carcinoma Extraembryonic structures Embryonic structures Yolk sac tumor Choriocarcinoma Teratoma

y ne og ci ol di th Me Pa of ity of ty rs te ul ive itu ac n st F U In rst les Fi har C

y ne og ci ol di th Me Pa of ity of ty rs te ul ive itu ac n st F U In rst les Fi har C